Skip to main content

32 Result(s)

within M. **gliang Remove this filter Cell Biology Remove this filter Internal Medicine Remove this filter Medicine/Public Health, general Remove this filter Stem Cells Remove this filter

Page of 2 next disabled
and

  1. No Access

    Article

    Second malignancies after autologous hematopoietic cell transplantation in children

    Childhood autologous hematopoietic cell transplant (auto-HCT) survivors can be at risk for secondary malignant neoplasms (SMNs). We assembled a cohort of 1487 pediatric auto-HCT recipients to investigate the i...

    K E Danner-Koptik, N S Majhail, R Brazauskas, Z Wang… in Bone Marrow Transplantation (2013)

  2. No Access

    Article

    Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options

    Bronchiolitis obliterans (BO) following allogeneic haematopoietic SCT (HSCT) is a serious complication affecting 1.7–26% of the patients, with a reported mortality rate of 21–100%. It is considered a manifesta...

    H H Uhlving, F Buchvald, C J Heilmann, K G Nielsen… in Bone Marrow Transplantation (2012)

  3. No Access

    Article

    The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignancies

    We performed a Phase I/II clinical trial to study the feasibility, toxicity and efficacy of allogeneic cytokine-induced killer (CIK) cell expansion, and treatment for patients with haematological malignancies ...

    Y-C Linn, M Niam, S Chu, A Choong, H-X Yong, K-K Heng… in Bone Marrow Transplantation (2012)

  4. No Access

    Article

    Effects of Azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT—a randomized double-blinded placebo-controlled study

    Bronchiolitis obliterans syndrome (BOS) is an important complication after hematopoietic SCT (HSCT). Recent observations suggested that azithromycin might improve lung function in BOS after HSCT. We conducted ...

    D C L Lam, B Lam, M K Y Wong, C Lu, W Y Au, E W C Tse… in Bone Marrow Transplantation (2011)

  5. No Access

    Article

    Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants?

    Approaches to determine whether one transplant-related therapy is better than another include: (1) using experimental data, such as those from randomized controlled trials (RCTs); (2) using observational data,...

    R P Gale, M Eapen, B Logan, M-J Zhang, H M Lazarus in Bone Marrow Transplantation (2009)

  6. No Access

    Article

    Therapeutic potential of non-adherent BM-derived mesenchymal stem cells in tissue regeneration

    We demonstrated that non-adherent BM cells (NA-BMCs) can be expanded in suspension and give rise to multiple mesenchymal phenotypes including fibroblastic, osteoblastic, chondrocytic and adipocytic as well as ...

    Z L Zhang, J Tong, R N Lu, A M Scutt, D Goltzman, D S Miao in Bone Marrow Transplantation (2009)

  7. No Access

    Article

    Current status of hematopoietic stem cell transplantation in Taiwan

    In Taiwan, hematopoietic SCT (HSCT) has been used to treat patients with hematological diseases since 1983. Since then, more than 2200 patients have undergone HSCT in 15 large hospitals. The disease entities i...

    P-M Chen, L-T Hsiao, M-Huang Chen, P M-S Chang, C-Y Liu… in Bone Marrow Transplantation (2008)

  8. No Access

    Article

    Symptom burden in patients undergoing autologous stem-cell transplantation

    Patients who undergo autologous peripheral blood stem cell (PBSC) transplantation experience multiple symptoms that adversely affect quality of life. We assessed symptoms during the acute phase of autologous P...

    K O Anderson, S A Giralt, T R Mendoza, J O Brown… in Bone Marrow Transplantation (2007)

  9. No Access

    Article

    Ex vivo expansion of enriched CD34+ cells from neonatal blood in the presence of thrombopoietin, a comparison with cord blood and bone marrow

    Neonatal blood (NB) contains substantial numbers of stem and progenitor cells which decline rapidly after birth. Using a combination of cord blood (CB) and NB, we performed a successful, sibling transplant for...

    J Liu, K Li, PMP Yuen, TF Fok, FW Yau, M Yang, CK Li in Bone Marrow Transplantation (1999)

  10. No Access

    Article

    Niemann–Pick disease type C (a cellular cholesterol lipidosis) treated by bone marrow transplantation

    Bone marrow transplantation (BMT) has been used for a wide variety of lysosomal storage diseases with encouraging results. We report a 3-year 5-month-old girl with Niemann–Pick type C disease (NPC) who receive...

    Y-S Hsu, W-L Hwu, S-F Huang, M-Y Lu, R-L Chen, D-T Lin… in Bone Marrow Transplantation (1999)

  11. No Access

    Article

    T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia

    To increase the stem cell content of T cell-depleted bone marrow transplants (BMT), we treated 12 patients with hematological malignancies with BMT from HLA-identical sibling donors given G-CSF 10 μg/kg/day fo...

    DA Mavroudis, EJ Read, J Molldrem, A Raptis, M Plante… in Bone Marrow Transplantation (1998)

  12. No Access

    Article

    Counterflow centrifugal elutriation as a method of T cell depletion may cause loss of immature CD34+ cells

    Counterflow centrifugal elutriation (CCE) is capable of separating cells on the basis of size. CCE has been used successfully to deplete allogeneic bone marrow (BM) grafts of T lymphocytes to decrease the risk...

    Q Chang, K Harvey, L Akard, J Thompson, M Dugan, D English… in Bone Marrow Transplantation (1997)

Page of 2 next disabled